HYGEIA HEALTH (06078) saw its share price rally more than 12% following the release of its financial results. As of the time of writing, the stock was trading up 12.41% at HK$10.6, with turnover reaching HK$33.18 million.
In its interim results for fiscal year 2026, HYGEIA HEALTH reported first-half revenue of RMB 1.96 billion, a year-on-year decline of 1.4%. Net profit came in at RMB 260 million, up 4.7% year-on-year, while adjusted net profit reached RMB 270 million, reflecting a 1.5% increase year-on-year and a robust 38.1% growth quarter-over-quarter. The company's gross margin stood at 27.4%, with an adjusted net margin of 13.6%, both showing signs of stabilization and improvement compared to the same period last year.
During the period, patient visits totaled approximately 2.3 million, marking a 4.1% increase year-on-year. Surgical volume reached around 46,000 procedures, up 8.2% year-on-year, with Grade III and IV surgeries accounting for roughly 21,000 procedures, a notable 17.8% surge year-on-year.
According to the company announcement, HYGEIA HEALTH unveiled a share buyback program worth RMB 300 million in December 2025. As of the announcement date, the company has repurchased 12.85 million shares, representing approximately 2.08% of its total share capital, with cumulative funds utilized reaching around RMB 120 million. The buyback plan remains in active execution.
In June of this year, the company further disclosed that its board has approved a shareholder return plan. Under this initiative, HYGEIA HEALTH intends to allocate approximately RMB 500 million annually over the three fiscal years ending December 31, 2028, to provide returns to shareholders through share buybacks and/or dividend distributions.
Comments